Here are three things to know:
1. The privately-held company recently received FDA 510(k) clearance for its Voyant System, a sterile single-use, disposable retractor device with integrated visualization technology for MIS.
2. In 2017, Viseon Spine received $5 million in a series-A financing round.
3. Jeffrey Valko serves as the company’s president and CEO. He has more than 25 years of medical device industry experience.
More articles on devices:
Medacta appoints general manager of U.S. spine division: 3 insights
Medtronic, DePuy Synthes & more: 11 device company launches, releases
5 things to know about NuVasive’s new CEO J. Christopher Barry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
